NN

Naveenkumar Ningayya Sthavarmath

Active Director Director DIN 11131792
DIN 11131792 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Naveenkumar Ningayya Sthavarmath

Data last updated:

Naveenkumar Ningayya Sthavarmath is a Director at Medisync Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11131792
Primary Designation Director
Industry Pharma
First Appointment 30 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20252025Active

Board colleagues of Naveenkumar Ningayya Sthavarmath

NameDINCompanyDesignation
Priyanka11131793Medisync Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medisync Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naveenkumar Ningayya Sthavarmath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveenkumar Ningayya Sthavarmath

Naveenkumar Ningayya Sthavarmath currently holds 1 directorship: Medisync Pharmaceuticals Private Limited (Director, since 30 May 2025).

Naveenkumar Ningayya Sthavarmath was first appointed on 30 May 2025 as Director at Medisync Pharmaceuticals Private Limited.

The current boards of Naveenkumar Ningayya Sthavarmath's companies include Priyanka (Medisync Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available